Flupentixol/melitracen

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Flupentixol/melitracen
Combination of
Flupentixol Typical antipsychotic
Melitracen Tricyclic antidepressant
Clinical data
Legal status
  • ℞ (Prescription only)
Routes of
administration		 Oral
Identifiers
ATC code N06CA02 (WHO)
  (verify)

Flupentixol/melitracen (trade name Deanxit, Placida, Franxit, Anxidreg) is a combination of two psychoactive agents which has antidepressant properties. It is designed for short term usage only. It is produced by Lundbeck.[1]

Flupentixol/melitracen were banned in India by the country's Ministry of Health and Family Welfare on July 11, 2014,[2] and Lundbeck plans to take legal action to have the ban lifted.[3]

See also

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=Flupentixol/melitracen&oldid=695141325"